Patient after the cardiac operation
Conditions
Interventions
lactose(placebo) 7.5g/day 14days
JPS hange-kobokuto extract granule(for composition) 7.5g/day 14days
Sponsors
Tokyo Medical University Hachioji Medical Center Cardiovascular surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who will undergo cardiac surgery (including a sternal midline incision procedure) as a scheduled surgery in the Department of Cardiovascular Surgery at our hospital. 1) Men and women over 20 years old who can orally ingest hangekobokuto 2) Patients who received an explanation of the objective and content of this research, and in whom voluntary consent could be obtained
Exclusion criteria
Exclusion criteria: 1) Patients undergoing developing drug administration or patients scheduled for developing drug administration 2) Patients who are pregnant or who want to become pregnant during the study observation period, as well as patients who are lactating 3) Patients who are taking or are scheduled to take other kampo medicines 4) Patients with Parkinson's disease and cerebral infarction, and those who are prone to develop aspiration pneumonitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Swallowing reflex test | — |
Secondary
| Measure | Time frame |
|---|---|
| coughing reflection test Substance P quantitative examination in saliva Aspiration pneumonia incidence rate Amount of antibiotic | — |
Countries
Japan
Contacts
Public ContactKoji Kawago
Tokyo Medical University Hachioji Medical Center Cardiovascular surgery
Outcome results
None listed